As an endothelium-derived angiogenesis inhibitor regulating VEGF, VASH-1 can act on the downstream SIRT1/HIF1α and TGFβ1/Smad3 pathway simultaneously to regulate the pathological process of oxidative stress and fibrosis in DKD (possible molecular mechanism shown in Figure 9). This evidence concerns the gene HIF1A and diabetic kidney disease.